| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $61.4M | +50.6% |
| SG&A Expense | $15.7M | +46.5% |
| Operating Income | -$77.1M | -49.7% |
| Pre-tax Income | -$75.7M | -47.3% |
| Income Tax | $3K | +50.0% |
| Net Income | -$75.7M | -47.3% |
| EPS (Basic) | -$2.71 | -2.3% |
| EPS (Diluted) | -$2.71 | -2.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.0M | +150.0% |
| Short-term Investments | $68.5M | -40.7% |
| Current Assets | $133.6M | -8.6% |
| Total Assets | $135.2M | -8.1% |
| Current Liabilities | $22.0M | +34.6% |
| Total Liabilities | $22.1M | +33.1% |
| Stockholders' Equity | $113.0M | -13.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.2M | -68.7% |
| Capital Expenditures | $8K | -93.8% |
| Investing Cash Flow | $47.2M | +139.9% |
| Financing Cash Flow | $53.2M | -56.3% |
| Free Cash Flow | -$63.2M | -68.1% |